CHI3L1 and lung carcinoma: Our previous study found that K284-6111 and Ebractenoid F, which are small-molecule inhibitors of CHI3L1 activity, yielded promising results in preclinical studies regarding the inhibition of the growth and metastasis of lung cancer cells52,53.